acne treatment

Reviewing Antibiotic Resistance in Acne Treatment

Staphylococcus aureus

In an effort to provide guidance to prescribers and encourage further research on the risk of antibiotic resistance in acne treatment, JAMA Dermatology published a clinical evidence synopsis (online June 21, 2017). Brandon L. Adler, MD, et al, reviewed five clinical trials published in 1987-2002 and 2007-2008. They found evidence that the widespread use of bacteriostatic antibiotics (topical erythromycin and clindamycin and oral tetracyclines) may encourage the emergence of antibiotic-resistant strains of P acnes, via point mutations.

Novan Appoints New CFO and CCO

Novan Therapeutics, developer of investigational acne product SB204, has announced the addition of two executives from the dermatology industry to the its leadership team. Richard Peterson, formerly of Medicis International, has joined the company as Chief Financial Officer and Brian Johnson, formerly of Galderma and Medicis International, as Chief Commercial Officer. Peterson will be responsible for the company's financial operations, investor relations and other corporate functions.

Skincare Product: Aknetrol

Main Image: 
Aknetrol

Aknetrol, by ZO Medical, is a 10% Benzoyl Peroxide acne treatment that decreases sebum production to prevent clogged pores and inflammation and reduce p.acnes proliferation. Tea tree oil in the formula provides added antibacterial properties, while additional ingredients moisturize the skin and provide antioxidant and anti-inflammatory properties. Contact: 888.893.1375, www.zoskinhealth.com.

Articles: